Advancing Scientific Discovery
Gilead Sciences funds independent and community-based research to advance science and improve health outcomes in virology, oncology, liver diseases, and inflammation.
Funder: Gilead Sciences
Due Dates: No current opportunities (RFPs are posted periodically)
Funding Amounts: Varies by program; Research Scholars Program awards typically $180,000 over two years; CBPR and Externally Sponsored Research amounts not specified.
Summary: Supports independent, innovative, and community-based research to advance knowledge and improve health outcomes in key therapeutic areas.
Key Information: Community-Based Participatory Research RFPs are not currently open; check program pages for updates.
Description
Gilead Sciences' Advancing Scientific Discovery initiative funds a range of research programs to foster scientific progress and address unmet needs in critical therapeutic areas. Their funding portfolio includes:
- Externally Sponsored Research (independent or collaborative studies on Gilead products or within areas of interest)
- The Research Scholars Program (support for innovative projects led by emerging investigators)
- Community-Based Participatory Research (CBPR) grants for community organizations conducting research to improve health outcomes
The initiative emphasizes the importance of diverse perspectives and community involvement to drive medical breakthroughs and enhance care quality. Priority therapeutic areas include virology (HIV, viral hepatitis), oncology (solid tumors), liver diseases, and inflammation.
